X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES NATCO PHARMA SUVEN LIFESCIENCES/
NATCO PHARMA
 
P/E (TTM) x 20.7 13.8 150.2% View Chart
P/BV x 4.1 2.9 140.6% View Chart
Dividend Yield % 0.6 1.5 36.4%  

Financials

 SUVEN LIFESCIENCES   NATCO PHARMA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-18
NATCO PHARMA
Mar-18
SUVEN LIFESCIENCES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs2511,080 23.2%   
Low Rs155671 23.1%   
Sales per share (Unadj.) Rs49.1592.1 8.3%  
Earnings per share (Unadj.) Rs9.7188.4 5.2%  
Cash flow per share (Unadj.) Rs11.4206.3 5.5%  
Dividends per share (Unadj.) Rs1.508.25 18.2%  
Dividend yield (eoy) %0.70.9 78.5%  
Book value per share (Unadj.) Rs60.3833.6 7.2%  
Shares outstanding (eoy) m127.2836.90 344.9%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.11.5 279.3%   
Avg P/E ratio x20.94.6 449.2%  
P/CF ratio (eoy) x17.84.2 419.7%  
Price / Book Value ratio x3.41.1 320.4%  
Dividend payout %15.44.4 352.5%   
Avg Mkt Cap Rs m25,82532,311 79.9%   
No. of employees `0001.14.8 22.2%   
Total wages/salary Rs m6133,256 18.8%   
Avg. sales/employee Rs Th5,832.64,522.5 129.0%   
Avg. wages/employee Rs Th571.5674.0 84.8%   
Avg. net profit/employee Rs Th1,153.81,439.0 80.2%   
INCOME DATA
Net Sales Rs m6,25321,848 28.6%  
Other income Rs m233404 57.6%   
Total revenues Rs m6,48522,252 29.1%   
Gross profit Rs m1,9829,284 21.3%  
Depreciation Rs m213662 32.2%   
Interest Rs m46154 30.1%   
Profit before tax Rs m1,9558,872 22.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7181,920 37.4%   
Profit after tax Rs m1,2376,952 17.8%  
Gross profit margin %31.742.5 74.6%  
Effective tax rate %36.721.6 169.8%   
Net profit margin %19.831.8 62.2%  
BALANCE SHEET DATA
Current assets Rs m5,62221,307 26.4%   
Current liabilities Rs m1,1685,920 19.7%   
Net working cap to sales %71.270.4 101.2%  
Current ratio x4.83.6 133.8%  
Inventory Days Days8173 111.2%  
Debtors Days Days36107 33.7%  
Net fixed assets Rs m3,32514,986 22.2%   
Share capital Rs m127369 34.5%   
"Free" reserves Rs m7,54730,353 24.9%   
Net worth Rs m7,67430,760 24.9%   
Long term debt Rs m140-   
Total assets Rs m9,13537,151 24.6%  
Interest coverage x43.258.6 73.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.6 116.4%   
Return on assets %14.019.1 73.4%  
Return on equity %16.122.6 71.3%  
Return on capital %26.029.3 88.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,06610,322 49.1%   
Fx outflow Rs m2,0012,978 67.2%   
Net fx Rs m3,0657,343 41.7%   
CASH FLOW
From Operations Rs m6994,636 15.1%  
From Investments Rs m-6-11,155 0.1%  
From Financial Activity Rs m-5776,509 -8.9%  
Net Cashflow Rs m116-18 -646.1%  

Share Holding

Indian Promoters % 63.4 52.0 121.8%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 0.0 16.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 26.0 140.4%  
Shareholders   37,287 25,395 146.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   ALEMBIC LTD  SHASUN PHARMA  PFIZER  FDC LTD.  SUN PHARMA  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

NBFCs Back in Focus; WPI Inflation at 2-Year Low, and Top Stocks in Action Today(Pre-Open)

On Friday, Indian share markets fell sharply during the closing hours and ended deep in the red.

Related Views on News

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

FM Nirmala Sitharaman Inherits an Economy Facing a Number of Headwinds(Sector Info)

Jun 4, 2019

The Indian economy is in a major slowdown. Will the new finance minister, Nirmala Sitharaman bring the much-needed reforms?

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Jun 14, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - JUBILANT LIFE SCIENCES COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS